Neogen Corporation

NEOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item May 2026 Feb 2026 Nov 2025 Aug 2025 May 2025 Feb 2025 Nov 2024 Aug 2024
Assets
Cash & Equivalents $185.5M $159.9M $145.3M $138.9M $129.0M $127.7M $140.2M $120.5M
Accounts Receivable $146.8M $137.1M $132.0M $138.5M $153.4M $160.1M $164.1M $167.6M
Inventory $144.3M $161.7M $162.8M $193.4M $190.8M $205.4M $198.3M $198.6M
Total Current Assets $604.6M $590.0M $574.6M $524.1M $576.9M $551.7M $570.4M $540.7M
Property, Plant & Equipment $329.8M $331.9M $332.4M $345.9M $339.1M $327.8M $310.6M $301.0M
Goodwill $1.05B $1.05B $1.05B $1.07B $1.06B $1.67B $1.67B $2.14B
Intangible Assets (Excl. Goodwill) $1.32B $1.34B $1.36B $1.39B $1.41B $1.44B $1.46B $1.49B
Total Assets $3.35B $3.36B $3.36B $3.38B $3.44B $4.04B $4.05B $4.50B
Liabilities
Accounts Payable $79.1M $75.2M $63.0M $76.6M $79.6M $72.2M $79.6M $61.5M
Total Current Liabilities $158.2M $150.6M $147.1M $146.2M $174.0M $141.2M $151.2M $122.7M
Long-Term Debt $793.7M $793.3M $792.9M $792.5M $874.8M $890.6M $889.9M $889.1M
Total Liabilities $1.25B $1.26B $1.26B $1.26B $1.37B $1.38B $1.39B $1.37B
Stockholders' Equity
Retained Earnings $-544.3M $-533.0M $-516.0M $-500.1M $-536.4M $75.8M $86.7M $543.0M
Total Stockholders' Equity $2.09B $2.10B $2.10B $2.12B $2.07B $2.66B $2.67B $3.14B
← Newer Page 1 of 9 Older →